Literature DB >> 6328889

Kinetics of 201Tl uptake in adenomas and well-differentiated carcinomas of the thyroid. A double isotope investigation with 99Tcm and 201Tl.

J Tennvall, J Palmer, A Biörklund, T Möller, J Ranstam, M Akerman.   

Abstract

A visually increased uptake of 201Tl chloride corresponding to a 'cold' (131I or 99Tcm ) thyroid nodule is mostly seen in well-differentiated carcinomas but also often in follicular adenomas. Since a visually increased uptake of 201Tl can be due to an increased initial uptake and/or a delayed elimination, an extended dynamic investigation was performed in patients with well-differentiated carcinomas or with follicular adenomas. Data were collected in a dynamic simultaneous double isotope ( 99Tcm + 201Tl) study up to 50 min after intravenous administration. Adenomas could be significantly separated from carcinomas by the elimination (p = 0.0001), but not by the initial uptake.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328889     DOI: 10.3109/02841868409135986

Source DB:  PubMed          Journal:  Acta Radiol Oncol        ISSN: 0349-652X


  3 in total

1.  Diagnosis of malignancy in thyroid nodules by factor analysis of spectral and dynamic structures: a simultaneous dual-isotope dynamic study with thallium-201 and iodine-131.

Authors:  B O Helal; F Frouin; G Schaison; D Leguillouzic; M E Pueyo; R Lebtahi; F Archambaud; A Desgrez; J P Bazin; R Di Paola
Journal:  Eur J Nucl Med       Date:  1992

2.  Early and delayed thallium-201 scintigraphy in thyroid nodules: the relationship between early thallium-201 uptake and perfusion.

Authors:  E Derebek; S Biberoglu; O Kut; S Yesil; S Saydam; M Yilmaz; O Yenici; E Igci; O Gokce; S Canda; A Büyükgebiz; A S Dogan; H Durak
Journal:  Eur J Nucl Med       Date:  1996-05

3.  Thallium-201 scintigraphy in the evaluation of thyroid nodules. A retrospective study of 246 cases.

Authors:  M Koizumi; H Taguchi; M Goto; T Nomura; T Watari
Journal:  Ann Nucl Med       Date:  1993-08       Impact factor: 2.668

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.